News & Insights

News & Insights

News 116 results

In the News · Source: The New York Times

August 13, 2019
Lisa Dwyer comments on the current regulatory environment for CBD

In the News · Source: Bloomberg Law

August 8, 2019
Seth Lundy discusses Medicare's proposal to add three new payment-reporting categories for device and drugmakers

In the News · Source: Law.com

August 6, 2019
Ashley Parrish, Jeff Telep, Lisa Dwyer and Jesse Snyder are counsel to Amarin Pharma on a new U.S. Supreme Court petition

In the News · Source: Law360 and Natural Products Insider

July 31, 2019
Ashley Parrish, Jeff Telep, Lisa Dwyer and Jesse Snyder advise Amarin Pharma on a petition to the U.S. Supreme Court to begin a U.S. International Trade Commission investigation into its claims

Cases & Deals

July 30, 2019
American Clinical Laboratory Association (ACLA) Wins Jurisdictional Decision in D.C. Circuit Court

In the News · Source: Drug Channels

July 16, 2019
John Shakow cited as “one of the country's leading legal experts on government drug pricing” discusses a drug's "ceiling price" under the 340B Drug Pricing program

In the News · Source: InsideHealthPolicy

July 10, 2019
David Farber explains Senate Finance Committee Chair Chuck Grassley's initiative to improve access to breakthrough drugs by letting state Medicaid programs pay over time for expensive drugs

In the News · Source: Pink Sheet

July 9, 2019
Lisa Dwyer comments on a recent ruling that Health and Human Services lacks congressional authority to require drug price disclosures in TV ads

In the News · Source: Bloomberg Law

July 3, 2019
David Farber explains why a Medicare rule change on home drug treatments has decreased provider pay

Recognition

May 24, 2019
King & Spalding Receives 2019 Novartis Global Outside Counsel Award

In the News · Source: Law360

May 6, 2019
Matthew Blaschke, Kathleen McCarthy, Lisa Dwyer, Anne Voigts, David Farber, Isra Bhatty, Cassie Rasmussen, and Blythe Kochsiek successfully settled a Lanham Act and unfair trade practices case on behalf of Amarin Pharma

Recognition

April 15, 2019
Twelve King & Spalding Attorneys to Serve on 2019 Law360 Editorial Advisory Boards